![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1534149
¼¼°èÀÇ ¸Á¸· ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð Á¶»ç : À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)Global Retinal Implants Market Size Study, by Type (Retina Implant Alpha AMS, Implantable Miniature Telescope, Argus II, Others), by End-use (Hospitals, Outpatient Facilities, Research & Manufacturing) and Regional Forecasts 2022-2032 |
¼¼°è ¸Á¸· ÀÓÇöõÆ® ½ÃÀåÀº 2023³â ¾à 4,844¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³âºÎÅÍ 2032³â±îÁö 8.6% ÀÌ»óÀÇ °Ç°ÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¸Á¸· ÀÓÇöõÆ®´Â ¸Á¸·»ö¼Òº¯¼ºÁõ, ³ëÈ È²¹Ýº¯¼º µî ÅðÇ༺ ¾ÈÁúȯÀ¸·Î ½Ã·ÂÀ» ÀÒÀº »ç¶÷µéÀ» µ½±â À§ÇØ °í¾ÈµÈ ÷´Ü »ýüÀÇÇÐ ¸¶ÀÌÅ©·ÎĨÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº ¸Á¸·ÀÇ ±¤¼ö¿ëü ¼¼Æ÷ÀÇ ¿È¸¦ ÀÏÀ¸ÄÑ ÁøÇ༺ ½Ã·Â ÀúÇϸ¦ À¯¹ßÇÕ´Ï´Ù. ±×·¯³ª ³ú¿¡ ½ÅÈ£¸¦ Àü´ÞÇÏ´Â ¸Á¸· ¾ÈÂÊÀÇ ½Å°æ¼¼Æ÷ Áß ÀϺδ º¸Á¸µÇ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¸Á¸· ÀÓÇöõÆ®´Â ºûÀ» Àü±â ½ÅÈ£·Î º¯È¯ÇÏ´Â °¨±¤ ´ÙÀÌ¿Àµå¸¦ ¹è¿ÇÑ ¸¶ÀÌÅ©·ÎĨÀ¸·Î ±¸¼ºµÇ¾î ȯÀÚÀÇ ºÎºÐÀûÀÎ ½Ã·Â ȸº¹À» µµ¿ï ¼ö ÀÖ½À´Ï´Ù.
¸Á¸· ÀÓÇöõÆ® ½ÃÀåÀº ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Àü±Ø, Ä«¸Þ¶ó Ĩ, ·»Áî, ¼ÒÇÁÆ®¿þ¾î ¹× ±âŸ µµ±¸°¡ ÀåÂøµÈ ½Ã·Â ȸº¹À» À§ÇÑ ½ÂÀÎµÈ Àåºñ´Â ȯÀÚÀÇ »îÀÇ ÁúÀ» Å©°Ô Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Argus II´Â ¼ÒÇü À̽ÄÇü ¸Á¿ø°æÀ¸·Î »ç¿ëÀÌ Æí¸®Çϰí ȯÀÚ°¡ Ãß°¡ ¼ö¼ú ¾øÀÌ ÀÏ»ó»ýȰÀ» ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ¶ÇÇÑ ÀϺ», Áß±¹, Àεµ¿Í °°Àº ½ÅÈï °æÁ¦±¹¿¡¼ ³ëÀÎ Àα¸ÀÇ Áõ°¡¿Í °¡Ã³ºÐ ¼ÒµæÀÇ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¤ºÎ¿Í ¹Î°£ ºÎ¹®ÀÇ ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ ¹ÌÃæÁ· Áö¿ª¿¡ ´ëÇÑ ÁøÃâ ³ë·ÂÀº ½ÃÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ºûÀ» Àü±â ½ÅÈ£·Î º¯È¯ÇÒ ¼ö ÀÖ´Â ¸Á¸· ÀÓÇöõÆ®¸¦ ÅëÇØ ÀÜÁ¸ ¸Á¸· ´º·±ÀÇ Àü±â ÀÚ±ØÀ» »ç¿ëÇÏ´Â °Íµµ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀÔ´Ï´Ù. ÀÌ ±â¼úÀº ȯÀÚÀÇ ½Ã·Â ȸº¹À» µ½°í Àü¹ÝÀûÀÎ »îÀÇ ÁúÀ» Çâ»ó½Ãŵ´Ï´Ù. ¿¹¸¦ µé¾î, ¿¬·É °ü·Ã Ȳ¹Ýº¯¼º(AMD)Àº Àü ¼¼°è Àα¸ÀÇ »ó´ç ºÎºÐÀ» Â÷ÁöÇϰí ÀÖÀ¸¸ç, 2020³â±îÁö ¾à 1¾ï 9,600¸¸ ¸íÀÇ È¯ÀÚ°¡ ¹ß»ýÇßÀ¸¸ç, 2040³â±îÁö 2¾ï 8,800¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ³ôÀº ȯÀÚ ¼ö´Â ¸Á¸· ÀÓÇöõÆ® ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù.
±×·¯³ª ½ÃÀåÀº ¸î °¡Áö µµÀü¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. º¹ÀâÇÑ ¼ö¼ú, ¿Ü·¡ ÀÓÇöõÆ®¿¡ ´ëÇÑ ´Ù¾çÇÑ »ý¹°ÇÐÀû ¹ÝÀÀ, ³ôÀº ¼ö¼ú ºñ¿ë µîÀÌ Å« °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¼úÀº º¹ÀâÇϱ⠶§¹®¿¡ ±â¼ú ¹× ¹æ¹ý¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ ±³À°ÀÌ ÇÊ¿äÇϸç, ¼º°øÀûÀΠäÅÃÀ» À§Çؼ´Â ȯÀÚ¸¦ ½ÅÁßÇÏ°Ô ¼±ÅÃÇØ¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ, ÀϺΠÁö¿ª¿¡¼´Â ÈÆ·ÃµÈ Àü¹®Àǰ¡ ºÎÁ·ÇÑ °Íµµ ¸Á¸· ÀÓÇöõÆ® ¼ö¿ä¸¦ ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
ºÏ¹Ì´Â ÅðÇ༺ ÁúȯÀÇ ³ôÀº À¯º´·ü°ú ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ Àü ¼¼°è ¸Á¸· ÀÓÇöõÆ® ½ÃÀå¿¡¼ °¡Àå ³ôÀº ¼öÀÍÀ» âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ Àα¸ Áõ°¡, °¡Ã³ºÐ ¼Òµæ Áõ°¡, Á¤ºÎ ¹× ¹Î°£ ºÎ¹®ÀÇ ÀÇ·áºñ ÁöÃâ Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÁÖ¿ä ½ÃÀå ±â¾÷µéÀÌ ¹Ì°³Ã´ Áö¿ªÀ¸·Î ÁøÃâÇÏ·Á´Â ³ë·ÂÀº ÀÌ Áö¿ª ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
The Global Retinal Implants Market is valued at approximately USD 48.44 million in 2023 and is anticipated to grow with a healthy growth rate of more than 8.6% over the forecast period 2024-2032. Retinal implants are sophisticated biomedical microchips designed to assist individuals who have lost their vision due to degenerative eye diseases such as retinitis pigmentosa and age-related macular degeneration. These conditions lead to the deterioration of photoreceptor cells in the retina, causing progressive vision loss. However, some inner retinal neurons that transmit signals to the brain are often preserved. Retinal implants, composed of microchips with arrays of light-sensitive diodes that convert light into electrical signals, can help patients regain partial vision.
The market for retinal implants is driven by several key factors. Approved devices for restoring vision, equipped with electrodes, camera chips, lenses, software, and other tools, can significantly enhance patients' quality of life. The Argus II, for example, is a small implantable telescope that is user-friendly and allows patients to engage in daily activities without the need for additional surgeries. Furthermore, the growing geriatric population and rising disposable income in developing economies like Japan, China, and India are expected to boost market growth. Increased healthcare spending by both governments and the private sector, along with efforts by leading market players to expand into underserved regions, further propel the market. Also, the use of electrical stimulation of residual retinal neurons through retinal implants, which can translate light into electrical signals, is another driver of market growth. This technology helps patients regain some vision and enhances their overall quality of life. Opportunities within the market are also substantial; for instance, Age-related Macular Degeneration (AMD) affects a significant portion of the global population, with an estimated 196 million people affected by 2020, projected to rise to 288 million by 2040. This high patient population drives the demand for retinal implants.
However, the market faces several challenges. Complex surgeries, varied biological responses to foreign implants, and high procedure costs are significant hurdles. The intricate nature of these surgeries necessitates extensive training in technology and methodology, as well as careful patient selection, to ensure successful adoption. Additionally, the scarcity of trained specialists in some regions hampers demand for retinal implants.
North America is expected to generate the highest revenue in the global retinal implants market due to the high prevalence of degenerative disorders and technological advancements. Meanwhile, the Asia-Pacific region is anticipated to hold the largest market share over the forecast period, driven by an increasing senior population, rising disposable income, and growing healthcare spending by both the government and private sectors. Efforts by key market players to expand into untapped regions further support regional market growth.